Study | Disease | Estimate from source | Estimate in Fig. 2 of Glantz et al. [14] |
---|---|---|---|
Alzahrani [34] | MI | 1.79 (1.20–2.66) | 1.79 (1.20–2.67) |
Falk [23] | 1.35 (1.08–1.70) | 1.35 (1.08–1.69) | |
Farsalinos [33] | 1.35 (0.80–2.27) | Only gave CHD estimate | |
Goldberg Scott [26] | 1.30 (0.66–2.55) | 1.30 (0.66–2.56) | |
Hirschtick [24] | 0.92 (0.30–2.82) | 0.93 (0.28–3.07) | |
Pooled A | 1.41 (1.18–1.68) | 1.41 (1.18–1.68) | |
Pooled B | 1.33 (1.06–1.66) | 1.33 (1.07–1.66) | |
Bricknell [35] | Stroke | 1.62 (1.18–2.31) | 1.62 (1.16–2.27) |
Falk [23] | 1.13 (0.90–1.43) | 1.14 (0.90–1.43) | |
Goldberg Scott [26] | 1.65 (0.94–2.89) | Same | |
Hirschtick [24] | 0.50 (0.14–1.79) | 0.50 (0.15–1.67) | |
Parekh [36] | 1.83 (1.06–3.17) | 1.83 (0.98–3.42) | |
Pooled A | 1.39 (1.06–1.82) | 1.37 (1.05–1.81) | |
Pooled B | 1.22 (0.76–1.94) | 1.19 (0.74–1.91) | |
Antwi [39] | COPD | 0.99 (0.67–1.46) | 0.99 (0.63–1.55) |
Barrameda [40] | 1.47 (1.13–1.92) | 1.83 (1.59–2.10) | |
Cook [42] | 1.10 (0.78–1.56) | 1.10 (0.74–1.64) | |
Kim [44] | 1.25 (0.69–2.27) | Same | |
Osei [45] | 1.66 (1.50–1.84) | 1.66 (1.46–1.89) | |
Parekh [46] | 1.55 (1.10–2.18) | 1.55 (1.00-2.40) | |
Paulin [47] | 1.04 (0.77–1.40) | 1.04 (0.74–1.46) | |
Perez [48] | 1.43 (1.12–1.85) | 1.43 (1.07–1.91) | |
Wills [49] | 1.32 (0.98–1.77) | Same | |
Wills [50] | 1.44 (1.21–1.71) | Same | |
Xie [52] | 1.16 (1.05–1.27) | 1.16 (1.03–1.31) | |
Pooled A | 1.32 (1.17–1.50) | 1.37 (1.19–1.57) | |
Pooled B | 1.31 (1.11–1.54) | 1.29 (1.07–1.54) |